Global Targeted Drugs for NSCLC Market Growth (Status and Outlook) 2019-2024

Date : Jun 2019

Formats :
Report Code : PMR133938205

Category : Pharmaceutical and Healthcare
No Of Pages : 157

Targeted Drugs for NSCLC Market


According to this study, over the next five years the Targeted Drugs for NSCLC market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Targeted Drugs for NSCLC business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Targeted Drugs for NSCLC market by product type, application, key companies and key regions.

This study considers the Targeted Drugs for NSCLC value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Target EGFR
Target ALK
Target ROS1
Target BRAF
Target MEK
Target VEGFR2
Target VEGF
Target MET
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Squamous Cell Carcinoma of NSCLC
Adenocarcinoma of NSCLC
Large Cell Carcinoma of NSCLC

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Allergan
Amgen
ARIAD Pharmaceuticals Takeda
Beacon Pharma Limited
BeiGene
Biocon
Boehringer-Ingelheim
Celgene Corporation
Drug International Limted
Fujifilm Kyowa Kirin Biologics
Genvio Pharma Limited
Hetero Drugs
ImClone Systems ? Eli Lilly
Incepta Pharmaceuticals
Mylan
Novartis
Pfizer
Reliance Lifesciences
Roche
AstraZeneca
Cipla
Teva
OSI Pharmaceuticals
Glenmark Pharmaceuticals
Natco Pharma

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Targeted Drugs for NSCLC market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Targeted Drugs for NSCLC market by identifying its various subsegments.
Focuses on the key global Targeted Drugs for NSCLC players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Targeted Drugs for NSCLC with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market growth potential, opportunities, drivers, industry-specific challenges and risks .
To project the size of Targeted Drugs for NSCLC submarkets, with respect to key regions along with their respective key countries .
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents

2019-2024 Global Targeted Drugs for NSCLC Market Report Status and Outlook

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Targeted Drugs for NSCLC Market Size 2014-2024
2.1.2 Targeted Drugs for NSCLC Market Size CAGR by Region
2.2 Targeted Drugs for NSCLC Segment by Type
2.2.1 Target EGFR
2.2.2 Target ALK
2.2.3 Target HER2
2.2.4 Target ROS1
2.2.5 Target BRAF
2.2.6 Target MEK
2.2.7 Target VEGFR2
2.2.8 Target VEGF
2.2.9 Target MET
2.3 Targeted Drugs for NSCLC Market Size by Type
2.3.1 Global Targeted Drugs for NSCLC Market Size Market Share by Type 2014-2019
2.3.2 Global Targeted Drugs for NSCLC Market Size Growth Rate by Type 2014-2019
2.4 Targeted Drugs for NSCLC Segment by Application
2.4.1 Squamous Cell Carcinoma of NSCLC
2.4.2 Adenocarcinoma of NSCLC
2.4.3 Large Cell Carcinoma of NSCLC
2.5 Targeted Drugs for NSCLC Market Size by Application
2.5.1 Global Targeted Drugs for NSCLC Market Size Market Share by Application 2014-2019
2.5.2 Global Targeted Drugs for NSCLC Market Size Growth Rate by Application 2014-2019

3 Global Targeted Drugs for NSCLC by Players
3.1 Global Targeted Drugs for NSCLC Market Size Market Share by Players
3.1.1 Global Targeted Drugs for NSCLC Market Size by Players 2017-2019
3.1.2 Global Targeted Drugs for NSCLC Market Size Market Share by Players 2017-2019
3.2 Global Targeted Drugs for NSCLC Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio CR3, CR5 and CR10 2017-2019
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Targeted Drugs for NSCLC by Regions
4.1 Targeted Drugs for NSCLC Market Size by Regions
4.2 Americas Targeted Drugs for NSCLC Market Size Growth
4.3 APAC Targeted Drugs for NSCLC Market Size Growth
4.4 Europe Targeted Drugs for NSCLC Market Size Growth
4.5 Middle East & Africa Targeted Drugs for NSCLC Market Size Growth

5 Americas
5.1 Americas Targeted Drugs for NSCLC Market Size by Countries
5.2 Americas Targeted Drugs for NSCLC Market Size by Type
5.3 Americas Targeted Drugs for NSCLC Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Targeted Drugs for NSCLC Market Size by Countries
6.2 APAC Targeted Drugs for NSCLC Market Size by Type
6.3 APAC Targeted Drugs for NSCLC Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Targeted Drugs for NSCLC by Countries
7.2 Europe Targeted Drugs for NSCLC Market Size by Type
7.3 Europe Targeted Drugs for NSCLC Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Targeted Drugs for NSCLC by Countries
8.2 Middle East & Africa Targeted Drugs for NSCLC Market Size by Type
8.3 Middle East & Africa Targeted Drugs for NSCLC Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Targeted Drugs for NSCLC Market Forecast
10.1 Global Targeted Drugs for NSCLC Market Size Forecast 2019-2024
10.2 Global Targeted Drugs for NSCLC Forecast by Regions
10.2.1 Global Targeted Drugs for NSCLC Forecast by Regions 2019-2024
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Targeted Drugs for NSCLC Forecast by Type
10.8 Global Targeted Drugs for NSCLC Forecast by Application

11 Key Players Analysis
11.1 Allergan
11.1.1 Company Details
11.1.2 Targeted Drugs for NSCLC Product Offered
11.1.3 Allergan Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share 2017-2019
11.1.4 Main Business Overview
11.1.5 Allergan News
11.2 Amgen
11.2.1 Company Details
11.2.2 Targeted Drugs for NSCLC Product Offered
11.2.3 Amgen Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share 2017-2019
11.2.4 Main Business Overview
11.2.5 Amgen News
11.3 ARIAD Pharmaceuticals Takeda
11.3.1 Company Details
11.3.2 Targeted Drugs for NSCLC Product Offered
11.3.3 ARIAD Pharmaceuticals Takeda Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share 2017-2019
11.3.4 Main Business Overview
11.3.5 ARIAD Pharmaceuticals Takeda News
11.4 Beacon Pharma Limited
11.4.1 Company Details
11.4.2 Targeted Drugs for NSCLC Product Offered
11.4.3 Beacon Pharma Limited Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share 2017-2019
11.4.4 Main Business Overview
11.4.5 Beacon Pharma Limited News
11.5 BeiGene
11.5.1 Company Details
11.5.2 Targeted Drugs for NSCLC Product Offered
11.5.3 BeiGene Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share 2017-2019
11.5.4 Main Business Overview
11.5.5 BeiGene News
11.6 Biocon
11.6.1 Company Details
11.6.2 Targeted Drugs for NSCLC Product Offered
11.6.3 Biocon Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share 2017-2019
11.6.4 Main Business Overview
11.6.5 Biocon News
11.7 Boehringer-Ingelheim
11.7.1 Company Details
11.7.2 Targeted Drugs for NSCLC Product Offered
11.7.3 Boehringer-Ingelheim Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share 2017-2019
11.7.4 Main Business Overview
11.7.5 Boehringer-Ingelheim News
11.8 Celgene Corporation
11.8.1 Company Details
11.8.2 Targeted Drugs for NSCLC Product Offered
11.8.3 Celgene Corporation Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share 2017-2019
11.8.4 Main Business Overview
11.8.5 Celgene Corporation News
11.9 Drug International Limted
11.9.1 Company Details
11.9.2 Targeted Drugs for NSCLC Product Offered
11.9.3 Drug International Limted Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share 2017-2019
11.9.4 Main Business Overview
11.9.5 Drug International Limted News
11.10 Fujifilm Kyowa Kirin Biologics
11.10.1 Company Details
11.10.2 Targeted Drugs for NSCLC Product Offered
11.10.3 Fujifilm Kyowa Kirin Biologics Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share 2017-2019
11.10.4 Main Business Overview
11.10.5 Fujifilm Kyowa Kirin Biologics News
11.11 Genvio Pharma Limited
11.12 Hetero Drugs
11.13 ImClone Systems ? Eli Lilly
11.14 Incepta Pharmaceuticals
11.15 Mylan
11.16 Novartis
11.17 Pfizer
11.18 Reliance Lifesciences
11.19 Roche
11.20 AstraZeneca
11.21 Cipla
11.22 Teva
11.23 OSI Pharmaceuticals
11.24 Glenmark Pharmaceuticals
11.25 Natco Pharma

12 Research Findings and Conclusion
List of Tables and Figures

Table Product Specifications of Targeted Drugs for NSCLC
Figure Targeted Drugs for NSCLC Report Years Considered
Figure Market Research Methodology
Figure Global Targeted Drugs for NSCLC Market Size Growth Rate 2014-2024 ($ Millions)
Table Targeted Drugs for NSCLC Market Size CAGR by Region 2014-2024 ($ Millions)
Table Major Players of Target EGFR
Table Major Players of Target ALK
Table Major Players of Target HER2
Table Major Players of Target ROS1
Table Major Players of Target BRAF
Table Major Players of Target MEK
Table Major Players of Target VEGFR2
Table Major Players of Target VEGF
Table Major Players of Target MET
Table Market Size by Type (2014-2019) ($ Millions)
Table Global Targeted Drugs for NSCLC Market Size Market Share by Type (2014-2019)
Figure Global Targeted Drugs for NSCLC Market Size Market Share by Type (2014-2019)
Figure Global Target EGFR Market Size Growth Rate
Figure Global Target ALK Market Size Growth Rate
Figure Global Target HER2 Market Size Growth Rate
Figure Global Target ROS1 Market Size Growth Rate
Figure Global Target BRAF Market Size Growth Rate
Figure Global Target MEK Market Size Growth Rate
Figure Global Target VEGFR2 Market Size Growth Rate
Figure Global Target VEGF Market Size Growth Rate
Figure Global Target MET Market Size Growth Rate
Figure Targeted Drugs for NSCLC Consumed in Squamous Cell Carcinoma of NSCLC
Figure Global Targeted Drugs for NSCLC Market: Squamous Cell Carcinoma of NSCLC (2014-2019) ($ Millions)
Figure Global Squamous Cell Carcinoma of NSCLC YoY Growth ($ Millions)
Figure Targeted Drugs for NSCLC Consumed in Adenocarcinoma of NSCLC
Figure Global Targeted Drugs for NSCLC Market: Adenocarcinoma of NSCLC (2014-2019) ($ Millions)
Figure Global Adenocarcinoma of NSCLC YoY Growth ($ Millions)
Figure Targeted Drugs for NSCLC Consumed in Large Cell Carcinoma of NSCLC
Figure Global Targeted Drugs for NSCLC Market: Large Cell Carcinoma of NSCLC (2014-2019) ($ Millions)
Figure Global Large Cell Carcinoma of NSCLC YoY Growth ($ Millions)
Table Global Targeted Drugs for NSCLC Market Size by Application (2014-2019) ($ Millions)
Table Global Targeted Drugs for NSCLC Market Size Market Share by Application (2014-2019)
Figure Global Targeted Drugs for NSCLC Market Size Market Share by Application (2014-2019)
Figure Global Targeted Drugs for NSCLC Market Size in Squamous Cell Carcinoma of NSCLC Growth Rate
Figure Global Targeted Drugs for NSCLC Market Size in Adenocarcinoma of NSCLC Growth Rate
Figure Global Targeted Drugs for NSCLC Market Size in Large Cell Carcinoma of NSCLC Growth Rate
Table Global Targeted Drugs for NSCLC Revenue by Players (2017-2019) ($ Millions)
Table Global Targeted Drugs for NSCLC Revenue Market Share by Players (2017-2019)
Figure Global Targeted Drugs for NSCLC Revenue Market Share by Players in 2018
Table Global Targeted Drugs for NSCLC Key Players Head office and Products Offered
Table Targeted Drugs for NSCLC Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table Global Targeted Drugs for NSCLC Market Size by Regions 2014-2019 ($ Millions)
Table Global Targeted Drugs for NSCLC Market Size Market Share by Regions 2014-2019
Figure Global Targeted Drugs for NSCLC Market Size Market Share by Regions 2014-2019
Figure Americas Targeted Drugs for NSCLC Market Size 2014-2019 ($ Millions)
Figure APAC Targeted Drugs for NSCLC Market Size 2014-2019 ($ Millions)
Figure Europe Targeted Drugs for NSCLC Market Size 2014-2019 ($ Millions)
Figure Middle East & Africa Targeted Drugs for NSCLC Market Size 2014-2019 ($ Millions)
Table Americas Targeted Drugs for NSCLC Market Size by Countries (2014-2019) ($ Millions)
Table Americas Targeted Drugs for NSCLC Market Size Market Share by Countries (2014-2019)
Figure Americas Targeted Drugs for NSCLC Market Size Market Share by Countries in 2018
Table Americas Targeted Drugs for NSCLC Market Size by Type (2014-2019) ($ Millions)
Table Americas Targeted Drugs for NSCLC Market Size Market Share by Type (2014-2019)
Figure Americas Targeted Drugs for NSCLC Market Size Market Share by Type in 2018
Table Americas Targeted Drugs for NSCLC Market Size by Application (2014-2019) ($ Millions)
Table Americas Targeted Drugs for NSCLC Market Size Market Share by Application (2014-2019)
Figure Americas Targeted Drugs for NSCLC Market Size Market Share by Application in 2018
Figure United States Targeted Drugs for NSCLC Market Size Growth 2014-2019 ($ Millions)
Figure Canada Targeted Drugs for NSCLC Market Size Growth 2014-2019 ($ Millions)
Figure Mexico Targeted Drugs for NSCLC Market Size Growth 2014-2019 ($ Millions)
Table APAC Targeted Drugs for NSCLC Market Size by Countries (2014-2019) ($ Millions)
Table APAC Targeted Drugs for NSCLC Market Size Market Share by Countries (2014-2019)
Figure APAC Targeted Drugs for NSCLC Market Size Market Share by Countries in 2018
Table APAC Targeted Drugs for NSCLC Market Size by Type (2014-2019) ($ Millions)
Table APAC Targeted Drugs for NSCLC Market Size Market Share by Type (2014-2019)
Figure APAC Targeted Drugs for NSCLC Market Size Market Share by Type in 2018
Table APAC Targeted Drugs for NSCLC Market Size by Application (2014-2019) ($ Millions)
Table APAC Targeted Drugs for NSCLC Market Size Market Share by Application (2014-2019)
Figure APAC Targeted Drugs for NSCLC Market Size Market Share by Application in 2018
Figure China Targeted Drugs for NSCLC Market Size Growth 2014-2019 ($ Millions)
Figure Japan Targeted Drugs for NSCLC Market Size Growth 2014-2019 ($ Millions)
Figure Korea Targeted Drugs for NSCLC Market Size Growth 2014-2019 ($ Millions)
Figure Southeast Asia Targeted Drugs for NSCLC Market Size Growth 2014-2019 ($ Millions)
Figure India Targeted Drugs for NSCLC Market Size Growth 2014-2019 ($ Millions)
Figure Australia Targeted Drugs for NSCLC Market Size Growth 2014-2019 ($ Millions)
Table Europe Targeted Drugs for NSCLC Market Size by Countries (2014-2019) ($ Millions)
Table Europe Targeted Drugs for NSCLC Market Size Market Share by Countries (2014-2019)
Figure Europe Targeted Drugs for NSCLC Market Size Market Share by Countries in 2018
Table Europe Targeted Drugs for NSCLC Market Size by Type (2014-2019) ($ Millions)
Table Europe Targeted Drugs for NSCLC Market Size Market Share by Type (2014-2019)
Figure Europe Targeted Drugs for NSCLC Market Size Market Share by Type in 2018
Table Europe Targeted Drugs for NSCLC Market Size by Application (2014-2019) ($ Millions)
Table Europe Targeted Drugs for NSCLC Market Size Market Share by Application (2014-2019)
Figure Europe Targeted Drugs for NSCLC Market Size Market Share by Application in 2018
Figure Germany Targeted Drugs for NSCLC Market Size Growth 2014-2019 ($ Millions)
Figure France Targeted Drugs for NSCLC Market Size Growth 2014-2019 ($ Millions)
Figure UK Targeted Drugs for NSCLC Market Size Growth 2014-2019 ($ Millions)
Figure Italy Targeted Drugs for NSCLC Market Size Growth 2014-2019 ($ Millions)
Figure Russia Targeted Drugs for NSCLC Market Size Growth 2014-2019 ($ Millions)
Figure Spain Targeted Drugs for NSCLC Market Size Growth 2014-2019 ($ Millions)
Table Middle East & Africa Targeted Drugs for NSCLC Market Size by Countries (2014-2019) ($ Millions)
Table Middle East & Africa Targeted Drugs for NSCLC Market Size Market Share by Countries (2014-2019)
Figure Middle East & Africa Targeted Drugs for NSCLC Market Size Market Share by Countries in 2018
Table Middle East & Africa Targeted Drugs for NSCLC Market Size by Type (2014-2019) ($ Millions)
Table Middle East & Africa Targeted Drugs for NSCLC Market Size Market Share by Type (2014-2019)
Figure Middle East & Africa Targeted Drugs for NSCLC Market Size Market Share by Type in 2018
Table Middle East & Africa Targeted Drugs for NSCLC Market Size by Application (2014-2019) ($ Millions)
Table Middle East & Africa Targeted Drugs for NSCLC Market Size Market Share by Application (2014-2019)
Figure Middle East & Africa Targeted Drugs for NSCLC Market Size Market Share by Application in 2018
Figure Egypt Targeted Drugs for NSCLC Market Size Growth 2014-2019 ($ Millions)
Figure South Africa Targeted Drugs for NSCLC Market Size Growth 2014-2019 ($ Millions)
Figure Israel Targeted Drugs for NSCLC Market Size Growth 2014-2019 ($ Millions)
Figure Turkey Targeted Drugs for NSCLC Market Size Growth 2014-2019 ($ Millions)
Figure GCC Countries Targeted Drugs for NSCLC Market Size Growth 2014-2019 ($ Millions)
Figure Global Targeted Drugs for NSCLC arket Size Forecast (2019-2024) ($ Millions)
Table Global Targeted Drugs for NSCLC Market Size Forecast by Regions (2019-2024) ($ Millions)
Table Global Targeted Drugs for NSCLC Market Size Market Share Forecast by Regions
Figure Americas Targeted Drugs for NSCLC Market Size 2019-2024 ($ Millions)
Figure APAC Targeted Drugs for NSCLC Market Size 2019-2024 ($ Millions)
Figure Europe Targeted Drugs for NSCLC Market Size 2019-2024 ($ Millions)
Figure Middle East & Africa Targeted Drugs for NSCLC Market Size 2019-2024 ($ Millions)
Figure United States Targeted Drugs for NSCLC Market Size 2019-2024 ($ Millions)
Figure Canada Targeted Drugs for NSCLC Market Size 2019-2024 ($ Millions)
Figure Mexico Targeted Drugs for NSCLC Market Size 2019-2024 ($ Millions)
Figure Brazil Targeted Drugs for NSCLC Market Size 2019-2024 ($ Millions)
Figure China Targeted Drugs for NSCLC Market Size 2019-2024 ($ Millions)
Figure Japan Targeted Drugs for NSCLC Market Size 2019-2024 ($ Millions)
Figure Korea Targeted Drugs for NSCLC Market Size 2019-2024 ($ Millions)
Figure Southeast Asia Targeted Drugs for NSCLC Market Size 2019-2024 ($ Millions)
Figure India Targeted Drugs for NSCLC Market Size 2019-2024 ($ Millions)
Figure Australia Targeted Drugs for NSCLC Market Size 2019-2024 ($ Millions)
Figure Germany Targeted Drugs for NSCLC Market Size 2019-2024 ($ Millions)
Figure France Targeted Drugs for NSCLC Market Size 2019-2024 ($ Millions)
Figure UK Targeted Drugs for NSCLC Market Size 2019-2024 ($ Millions)
Figure Italy Targeted Drugs for NSCLC Market Size 2019-2024 ($ Millions)
Figure Russia Targeted Drugs for NSCLC Market Size 2019-2024 ($ Millions)
Figure Spain Targeted Drugs for NSCLC Market Size 2019-2024 ($ Millions)
Figure Egypt Targeted Drugs for NSCLC Market Size 2019-2024 ($ Millions)
Figure South Africa Targeted Drugs for NSCLC Market Size 2019-2024 ($ Millions)
Figure Israel Targeted Drugs for NSCLC Market Size 2019-2024 ($ Millions)
Figure Turkey Targeted Drugs for NSCLC Market Size 2019-2024 ($ Millions)
Figure GCC Countries Targeted Drugs for NSCLC Market Size 2019-2024 ($ Millions)
Table Global Targeted Drugs for NSCLC Market Size Forecast by Type (2019-2024) ($ Millions)
Table Global Targeted Drugs for NSCLC Market Size Market Share Forecast by Type (2019-2024)
Table Global Targeted Drugs for NSCLC Market Size Forecast by Application (2019-2024) ($ Millions)
Table Global Targeted Drugs for NSCLC Market Size Market Share Forecast by Application (2019-2024)
Table Allergan Basic Information, Head Office, Major Market Areas and Its Competitors
Table Allergan Targeted Drugs for NSCLC Revenue and Gross Margin (2017-2019)
Figure Allergan Targeted Drugs for NSCLC Market Share (2017-2019)
Table Amgen Basic Information, Head Office, Major Market Areas and Its Competitors
Table Amgen Targeted Drugs for NSCLC Revenue and Gross Margin (2017-2019)
Figure Amgen Targeted Drugs for NSCLC Market Share (2017-2019)
Table ARIAD Pharmaceuticals (Takeda) Basic Information, Head Office, Major Market Areas and Its Competitors
Table ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Revenue and Gross Margin (2017-2019)
Figure ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Market Share (2017-2019)
Table Beacon Pharma Limited Basic Information, Head Office, Major Market Areas and Its Competitors
Table Beacon Pharma Limited Targeted Drugs for NSCLC Revenue and Gross Margin (2017-2019)
Figure Beacon Pharma Limited Targeted Drugs for NSCLC Market Share (2017-2019)
Table BeiGene Basic Information, Head Office, Major Market Areas and Its Competitors
Table BeiGene Targeted Drugs for NSCLC Revenue and Gross Margin (2017-2019)
Figure BeiGene Targeted Drugs for NSCLC Market Share (2017-2019)
Table Biocon Basic Information, Head Office, Major Market Areas and Its Competitors
Table Biocon Targeted Drugs for NSCLC Revenue and Gross Margin (2017-2019)
Figure Biocon Targeted Drugs for NSCLC Market Share (2017-2019)
Table Boehringer-Ingelheim Basic Information, Head Office, Major Market Areas and Its Competitors
Table Boehringer-Ingelheim Targeted Drugs for NSCLC Revenue and Gross Margin (2017-2019)
Figure Boehringer-Ingelheim Targeted Drugs for NSCLC Market Share (2017-2019)
Table Celgene Corporation Basic Information, Head Office, Major Market Areas and Its Competitors
Table Celgene Corporation Targeted Drugs for NSCLC Revenue and Gross Margin (2017-2019)
Figure Celgene Corporation Targeted Drugs for NSCLC Market Share (2017-2019)
Table Drug International Limted Basic Information, Head Office, Major Market Areas and Its Competitors
Table Drug International Limted Targeted Drugs for NSCLC Revenue and Gross Margin (2017-2019)
Figure Drug International Limted Targeted Drugs for NSCLC Market Share (2017-2019)
Table Fujifilm Kyowa Kirin Biologics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Fujifilm Kyowa Kirin Biologics Targeted Drugs for NSCLC Revenue and Gross Margin (2017-2019)
Figure Fujifilm Kyowa Kirin Biologics Targeted Drugs for NSCLC Market Share (2017-2019)
Table Genvio Pharma Limited Basic Information, Head Office, Major Market Areas and Its Competitors
Table Hetero Drugs Basic Information, Head Office, Major Market Areas and Its Competitors
Table ImClone Systems ?(Eli Lilly) Basic Information, Head Office, Major Market Areas and Its Competitors
Table Incepta Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table Mylan Basic Information, Head Office, Major Market Areas and Its Competitors
Table Novartis Basic Information, Head Office, Major Market Areas and Its Competitors
Table Pfizer Basic Information, Head Office, Major Market Areas and Its Competitors
Table Reliance Lifesciences Basic Information, Head Office, Major Market Areas and Its Competitors
Table Roche Basic Information, Head Office, Major Market Areas and Its Competitors
Table AstraZeneca Basic Information, Head Office, Major Market Areas and Its Competitors
Table Cipla Basic Information, Head Office, Major Market Areas and Its Competitors
Table Teva Basic Information, Head Office, Major Market Areas and Its Competitors
Table OSI Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table Glenmark Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table Natco Pharma Basic Information, Head Office, Major Market Areas and Its Competitors
  Purchase Options for Report

Need More information

Call us :
USA : +1 7162260907
UK : +44 7441952057
....
sales@planetmarketreports.com

Why to choose PMR

PMR Market Research

Our syndicated research reports cover 50+ industry sectors offering you product and country wise breakup of the market along with niche data and insights that will help you make informed business decision. Our research is focused on the key segments of an industry that possess opportunities of growth.

  • Industrial ...
  • Business ....
  • Consumer ....
  • Peer ....

About Report

Planet Market Reports added Latest and detailed market study report that focuses on “Global Targeted Drugs for NSCLC Market" Which offers essential information based on fresh ideas into Global Targeted Drugs for NSCLC Market industry along with unique market analysis which covers current top Manufactures in Global Targeted Drugs for NSCLC Market, growth, Consumption Demand, challenges, Historical data, subjects wise Survey of each chapters, Regional Insights, and Advancing industry trends, which will help our clients to aim Global Targeted Drugs for NSCLC Market. In addition, the report helps the customers to get a brief idea about Future demand and specifications of products which ensures the driving long-term income and productivity of global market.